熱門資訊> 正文
BioCardia GAAP每股收益为-0.40美元
2025-08-12 01:58
- BioCardia press release (NASDAQ:BCDA): Q2 GAAP EPS of -$0.40.
- Net cash used in operations for the three months ended June 2025 was approximately $1.6 million, as compared to approximately $1.3 million for the three months ended June 2024. Net cash used in operations for the six months ended June 2025 was approximately $3.3 million, as compared to approximately $2.8 million for the six months ended June 2024.
More on BioCardia
- BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on BioCardia
- Historical earnings data for BioCardia
- Financial information for BioCardia
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
